Back
Lucid Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
46
LCID
Lucid Group
Last Price:
3.98
Seasonality Move:
9.17%
Buy
54
KYMR
Kymera Therapeutics
Last Price:
44.79
Seasonality Move:
25.63%
Sell
46
Lucid Group (LCID)
is a Sell
Is Lucid Group a Buy, Sell or Hold?
- The current Lucid Group [LCID] share price is $3.98. The Score for LCID is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- LCID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $44.77. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LCID Stock Price Chart
What is Lucid Group's stock price today?
-
The Lucid Group share price today is $3.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCID is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.77
The current trend is moderately bearish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
LCID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 59.58 | Buy |
Chaikin Money Flow: | 42424100 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.15 - 3.97) | Buy |
Bollinger Bands (100): | (2.59 - 3.57) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.88 | Buy |
Relative Strength Index (14 RSI): | 48.13 | Sell |
Chaikin Money Flow: | -245093 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.03 - 48.09) | Sell |
Bollinger Bands (100): | (32.8 - 44.58) | Buy |
LCID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.73 | Buy |
20-day SMA: | 3.68 | Buy |
50-day SMA: | 3.46 | Buy |
200-day SMA: | 3.25 | Buy |
8-day EMA: | 3.73 | Buy |
20-day EMA: | 3.66 | Buy |
50-day EMA: | 3.44 | Buy |
200-day EMA: | 3.73 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.33 | Sell |
20-day SMA: | 46.49 | Sell |
50-day SMA: | 43.27 | Buy |
200-day SMA: | 35.7 | Buy |
8-day EMA: | 46.22 | Sell |
20-day EMA: | 45.92 | Sell |
50-day EMA: | 43.32 | Buy |
200-day EMA: | 36.21 | Buy |
Lucid Group Earnings Growth & LCID Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.23 per share, and an increase next year of $0.25 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Lucid Group Technical Analysis
Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |